Stress-induced trained immunity in cardiovascular disease
心血管疾病中压力诱导的免疫力训练
基本信息
- 批准号:10635427
- 负责人:
- 金额:$ 53.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-17 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:ArteriogramAtherosclerosisBiological AssayBone MarrowBone Marrow AspirationBone Marrow TransplantationCardiovascular DiseasesCardiovascular systemCatecholaminesCell CompartmentationCell ReprogrammingCellsChronicChronic stressCoronary ArteriosclerosisCoronary arteryDevelopmentDiseaseEpigenetic ProcessEventExposure toFamilial HypercholesterolemiaGlucocorticoidsHeart failureHematopoieticHematopoietic stem cellsHormonesHumanImageImmuneImmunityImmunologic MemoryIn VitroInfectionInflammationInflammatoryInnate Immune SystemInterventionLigationMetabolicMethodsModificationMultiomic DataMusMyelogenousMyeloid CellsMyelopoiesisMyocardial InfarctionOutcomePatientsPeripheralPhenotypePheochromocytomaPositron-Emission TomographyPsychosocial StressQuestionnairesReportingRestRisk FactorsSamplingSterilityStimulusStressSystemTestingTherapeuticTrainingVaccinationWorkbiobankcardiovascular risk factorclinical imagingclinical translationcohortexperiencefluorodeoxyglucose positron emission tomographyhigh riskhormonal signalshuman modelimmune imagingin vivoinsightmonocytemouse modelmultiple omicsnanobiologicoptogeneticsoxidized low density lipoproteinperceived stressprofiles in patientsprogenitorprogramsrecruitstem cells
项目摘要
PROJECT SUMMARY
In the last decade, emerging evidence has unveiled that the innate immune system retains long-
term epigenetic and metabolic changes after infection or vaccination. This de facto innate immune memory
has been termed ‘trained immunity’ and is characterized by myeloid cells’ hyper-responsiveness following
a subsequent stimulus. Recent work has shown that sterile atherogenic/inflammatory triggers, such as
oxidized LDL or catecholamines, similarly induce a trained immunity phenotype through epigenetic and
metabolic reprogramming of the myeloid compartment. The long-term persistence of trained immunity in
vivo is due to the reprogramming of hematopoietic stem and progenitor cells (HSPC) in the bone marrow.
We have recently reported that monocytes isolated from patients with risk factors for CVD, such as
familial hypercholesterolemia or pheochromocytoma, display a ‘trained’ phenotype. Importantly, in patients
with established coronary artery disease, we found HSPCs reprogrammed towards a pro-inflammatory
myeloid lineage. Project 2 will focus on stress-induced trained immunity’s mechanistic aspects in
cardiovascular disease patients and mouse models. Our central hypothesis is that chronic stress induces
trained immunity via HSPC reprogramming, which exacerbates the development of atherosclerosis and
worsens the outcome of cardiovascular events.
In Aim 1, we will use deep phenotyping and imaging to study patients at high risk for cardiovascular
events in order to obtain an integrated view of stress-induced reprogramming of the myeloid cell
compartment. In Aim 2, we will study mice that were exposed to chronic mild psychosocial stress or to key
hormonal signals that promote peripheral effects on stress, followed by a rest period of 4 weeks. After the
rest period, stressed cohorts and non-stressed controls will undergo coronary artery ligation or induction of
atherosclerosis to test the hypothesis that preceding stress or exposure to stress hormones activates
trained immunity, thus increasing myelopoiesis and consequently worsening cardiovascular disease.
Our unique ability to profile patients’ HSPCs at Radboudumc, the human models, and the mouse
models that mimic them will yield critical insights into the relationship between cardiovascular disease and
psychosocial stress.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Willem Mulder其他文献
Willem Mulder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Willem Mulder', 18)}}的其他基金
Elucidating the role of trained immunity in kidney transplant patients
阐明训练有素的免疫力在肾移植患者中的作用
- 批准号:
10642596 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Translational imaging and nanomedicine in inflammatory atherosclerosis
炎症性动脉粥样硬化的转化成像和纳米医学
- 批准号:
10116448 - 财政年份:2017
- 资助金额:
$ 53.46万 - 项目类别:
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
8696070 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
Anti-inflammatory nanoparticle formulations to treat atherosclerosis
治疗动脉粥样硬化的抗炎纳米颗粒制剂
- 批准号:
9279233 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
PET/MRI to study nanotherapy in atherosclerosis
PET/MRI 研究动脉粥样硬化的纳米疗法
- 批准号:
8962168 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
PET/MRI to study nanotherapy in atherosclerosis
PET/MRI 研究动脉粥样硬化的纳米疗法
- 批准号:
8801993 - 财政年份:2014
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8699161 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8917868 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8507620 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
A Surface Activable Nanoemulsion platform for Breast Cancer Diagnosis and Therapy
用于乳腺癌诊断和治疗的表面活性纳米乳平台
- 批准号:
8327177 - 财政年份:2011
- 资助金额:
$ 53.46万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
- 批准号:
10974007 - 财政年份:2023
- 资助金额:
$ 53.46万 - 项目类别: